1 – 10 of 19
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Benign prostatic hyperplasia/obstruction ameliorated using a soluble guanylate cyclase activator
(
- Contribution to journal › Article
- 2021
-
Mark
Impact of Cernitin™ on induced chronic prostatitis in animal model for understanding management of lower urinary tract symptoms
(
- Contribution to journal › Article
- 2019
-
Mark
Medical therapy versus transurethral resection of the prostate (TURP) for the treatment of symptomatic benign prostatic enlargement (BPE) : a cost minimisation analysis
(
- Contribution to journal › Article
-
Mark
Systematic Review of Combination Drug Therapy for Non-neurogenic Lower Urinary Tract Symptoms
(
- Contribution to journal › Scientific review
-
Mark
The effects of Cernitin® on inflammatory parameters and benign prostatic hyperplasia : An in vitro study
(
- Contribution to journal › Article
- 2009
-
Mark
Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia
(
- Contribution to journal › Article
- 2008
-
Mark
The Identification of a Novel Stromal Stem/Progenitor Cell Phenotype in the Human Adult Prostate
2008) 23rd Annual Congress of the European Association of Urology, 2008 In European Urology Supplements 7(3). p.93-93(
- Contribution to journal › Published meeting abstract
- 2007
-
Mark
Immunohistochemical Distribution of Cyclic GMP-Dependent Protein Kinase-1 in Human Prostate Tissue.
(
- Contribution to journal › Article
- 2006
-
Mark
Under what conditions is feedback microwave thermotherapy (ProstaLund Feedback Treatment) cost-effective in comparison with alpha-blockade in the treatment of benign prostatic hyperplasia and lower urinary tract symptoms?
(
- Contribution to journal › Article
-
Mark
Development of Feedback Microwave Thermotherapy in Symptomatic Benign Prostatic Hyperplasia.
(
- Thesis › Doctoral thesis (compilation)